BCV
VYNE icon

Banque Cantonale Vaudoise’s VYNE Therapeutics VYNE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– – – 1367
2022
Q1 		– Hold
0
– – – 1388
2021
Q4 		– Sell
-4,444
Closed -$95.4K – 1406
2021
Q3 		$111K Sell
4,444
-6,667
-60% -$259K ﹤0.01% 920
2021
Q2 		$702K Buy
+11,111
New +$880K 0.03% 514

Other funds holding VYNE

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Banque Cantonale Vaudoise's VYNE Position: Q2 2022 in Review

Banque Cantonale Vaudoise held its VYNE Therapeutics (VYNE) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Banque Cantonale Vaudoise first reported a position in VYNE in Q2 2021 and has held it in 2 quarters since. The position peaked at $702K in Q2 2021. 41 funds tracked by Wall St. Rank hold VYNE as of Q2 2022.

  • Banque Cantonale Vaudoise held 0 shares of VYNE Therapeutics worth $0 as of Q2 2022.
  • Banque Cantonale Vaudoise left its VYNE Therapeutics share count unchanged in Q2 2022.
  • VYNE Therapeutics made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2022, its #1367 holding.
  • Banque Cantonale Vaudoise first reported a position in VYNE Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • Banque Cantonale Vaudoise's VYNE Therapeutics position peaked at $702K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q2 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2022, filed 2 Aug 2022.